Sharekhan

Anthem Biosciences Ltd

Fri 29/08/2025,15:59:32 | NSE : ANTHEM

₹ 818.050.55 (0.07%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 820.90

Previous Close

₹ 817.50

Volume

665988

Mkt Cap ( Rs. Cr)

₹45942.51

High

₹ 837.50

Low

₹ 816.10

52 Week High

₹ 864.90

52 Week Low

₹ 701.90

Book Value Per Share

₹ 42.92

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Anthem Biosciences Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

818.05

5111

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

5111

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anthem Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Aug 2025, 4:16PM Anthem Biosciences Limited has informed the Exchange about Transcript
  • Anthem Biosciences Q1 net profit jumps 73.82% at Rs 148.34 cr

    18 Aug 2025, 4:30PM The company reported standalone net profit of Rs 148.34 crore for the quarter ended June 30, 2025 as compared to Rs 85.34 crore in the same period las
  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    18 Aug 2025, 4:08PM Earnings Call Transcripts for the Quarter ended June 30, 2025
  • Anthem Biosciences - Copy of Newspaper Publication

    14 Aug 2025, 4:09PM Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication related to Postal Ballot Notice
  • Anthem Biosciences - Copy of Newspaper Publication

    14 Aug 2025, 4:06PM Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication on Unaudited Standalone and Financial Results for the Quarter
  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Aug 2025, 4:02PM Anthem Biosciences Limited has informed the Exchange about Link of Recording
  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    14 Aug 2025, 3:57PM Audio recording of Earnings Call for the quarter ended June 30, 2025
  • Anthem Biosciences - Shareholders meeting

    13 Aug 2025, 10:02PM Anthem Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot
  • Anthem Biosciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    13 Aug 2025, 9:59PM Please fine enclosed herewith Notice of Postal Ballot dated August 13, 2025, seeking approval of members for the resolution stated therein
  • Anthem Biosciences - Press Release

    13 Aug 2025, 9:25PM Anthem Biosciences Limited has informed the Exchange regarding a press release dated August 13, 2025, titled ""Press Release on the Unaudited Consolid
  • Anthem Biosciences - Investor Presentation

    13 Aug 2025, 9:22PM Anthem Biosciences Limited has informed the Exchange about Investor Presentation
  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    13 Aug 2025, 9:17PM Investor Presentation on Unaudited Consolidated Financial Statement for the Quarter ended June 30, 2025
  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    13 Aug 2025, 9:11PM Press release on the Unaudited Consolidated Financial Results for the quarter ended June 30, 2025.
  • Anthem Biosciences - Outcome Of Board Meeting Held On Wednesday, August 13, 2025

    13 Aug 2025, 8:48PM We would like to inform that Board at its meeting held today have approved financial results of the Company for the Quarter ended June 30, 2025
  • Anthem Biosciences - Outcome of Board Meeting

    13 Aug 2025, 8:37PM Anthem Biosciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
  • Anthem Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 13, 2025

    13 Aug 2025, 8:25PM Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regul
  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Aug 2025, 6:16PM Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regul
  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Aug 2025, 6:07PM Anthem Biosciences Limited has informed the Exchange about Schedule of meet
  • Anthem Biosciences - Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results For The Quarter

    8 Aug 2025, 5:47PM Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider a
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 12:00PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:11AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended July 18, 2025

    22 Jul 2025, 7:01AM As of July 2025, 74.69% is owned by Indian Promoters and 25.31% by Public. <p align=justify> Institutional holds 5.10% (Insurance Companies 0.38%) and
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:20PM Anthem Biosciences Limited has informed the Exchange regarding 'Appointment of Kfin Technologies Limited as the Registrar and Share Transfer Agent (RT
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:18PM Anthem Biosciences Limited has informed the Exchange regarding 'Appointment of Ms. Divya Prasad as the Compliance Officer of the Company'.
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:16PM Anthem Biosciences Limited has informed the Exchange regarding 'Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations,
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:14PM Anthem Biosciences Limited has informed the Exchange regarding 'Intimation Of Regulation 30(5) Of The Securities And Exchange Board Of India (Listing
  • Anthem Biosciences - Trading Window

    21 Jul 2025, 3:02PM Anthem Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation
  • Anthem Biosciences - Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And

    21 Jul 2025, 4:34PM Names of the Key Managerial Personnels of the Company who are authorised to determine the materiality of an event or information and for the purpose o
  • Anthem Biosciences - Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And

    21 Jul 2025, 4:26PM Intimation of continuation of Kfin Technologies Limited as the Registrar and Share Transfer Agent of Anthem Biosciences Limited
  • Anthem Biosciences - Appointment of Company Secretary and Compliance Officer

    21 Jul 2025, 4:03PM Intimation of continuation of Ms. Divya Prasad as the Compliance Officer of Anthem Biosciences Limited pursuant to Regulation 6(1) of the Securities a
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:50PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:40PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:30PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences announces launch of initial public offering

    9 Jul 2025, 12:00PM Anthem Biosciences Ltd. has announced public offering of 59561403 shares at a price of Rs 2.00 each for Cash at a Premium of Rs 568.00 per share. The

Key fundamentals

Evaluate the intrinsic value of Anthem Biosciences Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2582.167 2099.6616 1855.5501 1390.9533
Liabilities 2582.167 2099.6616 1855.5501 1390.9533
Equity 111.8154 111.8154 114.0974 8.7763
Gross Profit 689.01 504.8861 429.0579 565.4535
Net Profit 506.1875 374.7807 385.6711 405.9902
Cash From Operating Activities 439.8357 164.4076 318.9833 333.3458
NPM(%) 27.5 26.43 36.48 32.97
Revenue 1840.6491 1417.539 1056.9243 1231.256
Expenses 1151.6391 912.6529 627.8664 665.8025
ROE(%) 21 15.54 16 16.84

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anthem Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 949.10 1.51 20.39 7385.00 337.37 0.95
Amines and Plasticizers Ltd 220.92 0.89 30.56 4503.66 372.61 0.23
Indogulf Cropsciences Ltd 105.57 -1.13 0.00 1925.12 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.92 37114.04 346.70 0.43

Company Info

Our Company was originally incorporated as "Anthem Biosciences Private Limited" under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated June 13, 2006, issued by RoC. Subsequently, our Company was converted from a private company to a public company, pursuant to a board resolution dated October 18, 2024 and a resolution passed in the extraordinary general meeting of our Shareholders held on October 18, 2024 following which the name of our Company was changed to "Anthem Biosciences Limited" and a certificate of incorporation consequent upon conversion to public limited company was issued by the RoC on December 10, 2024.Major Events and Milestones:2006- Incorporation of our Company.2007- Commenced operations of our Company at Unit I and set up a custom synthesis plant with a capacity of 6 KL.2008- Commencement of the discovery biology services with a fermentation capacity of 2 KL.2010- Expanded the custom synthesis plant set up at Unit I increasing its capacity from 6 KL to 24 KL.2013- Received the first USFDA audit approval for Unit I.2016- Set up a high potent lab at Unit I - Bommasandra Facility.2017- Our Company, pursuant to an order dated November 30, 2017, amalgamated with Anthem Cellutions (India) Private Limited by way of an acquisition of 100% of its share capital.- Set up a solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1.- Commenced operations of our Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL.- Received the second USFDA audit approval for Unit I.2018- Anthem Cellutions (India) Private Limited amalgamated into our Company.2019- Received the third USFDA approval for Unit I.- Set up a flow chemistry lab at Unit I.2020- Commenced operations in biological facility 2 earmarked for a specific client.2022- Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.2023- Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.- Addition of Oligonucleotide lab in Unit I.- Set a cGMP scale continuous flow manufacturing facility for Unit II.2024- Received the: second USFDA audit approval for Unit II; first ANVISA audit approval for Unit I(1); and first ANVISA audit approval for Unit II(1).- Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III designed as a chemistry lab and customer synthesis pilot plant for development, technology transfer and scale-up projects.- Fermentation capacity expanded to 140 KL at Unit II.- Conversion of our Company into a public limited company, under the name "Anthem Biosciences Limited".2025- Received the fourth USFDA approval for Unit I.

Our Company was originally incorporated as "Anthem Biosciences Private Limited" under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated June 13, 2006, issued by RoC. Subsequently, our Company was converted from a private company to a public company, pursuant to a board resolution dated October 18, 2024 and a resolution passed in the extraordinary general meeting of our Shareholders held on October 18, 2024 following which the name of our Company was changed to "Anthem Biosciences Limited" and a certificate of incorporation consequent upon conversion to public limited company was issued by the RoC on December 10, 2024.Major Events and Milestones:2006- Incorporation of our Company.2007- Commenced operations of our Company at Unit I and set up a custom synthesis plant with a capacity of 6 KL.2008- Commencement of the discovery biology services with a fermentation capacity of 2 KL.2010- Expanded the custom synthesis plant set up at Unit I increasing its capacity from 6 KL to 24 KL.2013- Received the first USFDA audit approval for Unit I.2016- Set up a high potent lab at Unit I - Bommasandra Facility.2017- Our Company, pursuant to an order dated November 30, 2017, amalgamated with Anthem Cellutions (India) Private Limited by way of an acquisition of 100% of its share capital.- Set up a solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1.- Commenced operations of our Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL.- Received the second USFDA audit approval for Unit I.2018- Anthem Cellutions (India) Private Limited amalgamated into our Company.2019- Received the third USFDA approval for Unit I.- Set up a flow chemistry lab at Unit I.2020- Commenced operations in biological facility 2 earmarked for a specific client.2022- Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.2023- Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.- Addition of Oligonucleotide lab in Unit I.- Set a cGMP scale continuous flow manufacturing facility for Unit II.2024- Received the: second USFDA audit approval for Unit II; first ANVISA audit approval for Unit I(1); and first ANVISA audit approval for Unit II(1).- Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III designed as a chemistry lab and customer synthesis pilot plant for development, technology transfer and scale-up projects.- Fermentation capacity expanded to 140 KL at Unit II.- Conversion of our Company into a public limited company, under the name "Anthem Biosciences Limited".2025- Received the fourth USFDA approval for Unit I.

Read More

Parent Organisation

Anthem Biosciences Ltd.

Founded

13/06/2006

Managing Director

NSE Symbol

ANTHEMEQ

FAQ

The current price of Anthem Biosciences Ltd is ₹ 818.05.

The 52-week high for Anthem Biosciences Ltd is ₹ 837.50 and the 52-week low is ₹ 816.10.

The market capitalization of Anthem Biosciences Ltd is currently ₹ 45942.51. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anthem Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anthem Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anthem Biosciences Ltd shares.

The CEO of Anthem Biosciences Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT